PerkinElmer, Novartis Collaborate on Sickle Cell Disease Screening in Sub-Saharan Africa
PerkinElmer will provide training, consultations, support, and other services to the effort, as well as establish new laboratory facilities.
Precision Cancer Consortium Launches With Bayer, GSK, Roche, Novartis as Founding Members
The organization of pharmaceutical and biotechnology firms aims to increase access to genomic testing for cancer patients.
In Brief This Week: PerkinElmer, Chembio, Becton Dickinson, Fulgent Genetics, and More
News items for the in vitro diagnostic industry for the week of Sept. 20, 2021.
FDA Approves Foundation Medicine's Liquid Biopsy Test as CDx for Novartis' Tabrecta in NSCLC
The blood-based test is the second Foundation Medicine assay approved to ID patients eligible for the drug due to mutations leading to MET exon 14 skipping.
The firm has collaborated with Novartis to help pilot the new sickle cell disease test and a treatment in Ghana.
Nov 13, 2018
Health Canada Approves Two BCR-ABL Tests
Nov 27, 2017